Abano sees opportunities in Australia and NZ


"Consolidation activity in the dental sector in Australia is ongoing. Abano has received various expressions of interest, which may offer strategic opportunities and value to shareholders," it said in a statement.

The group said that it had "paused acquisitions in Australia", given current Australian acquisition multiples and trading conditions. It said that capital will be invested in New Zealand acquisitions to grow the existing Lumino network.

At the same time the group confirmed guidance for the year. Full year results to the end of May should see EBITDA of NZ$32.7m (US$22m) with NPAT of NZ$10.1m.

Abano shares slumped 32% at the end of March after it downgraded its earnings outlook, but have recovered since then. They closed the day up 17.85% at NZ$4.16.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

Renewed Middle East ties for Qatar

19 January, 2021

Might Gulf medical tourists now go to Qatar?

Dubai’s medical travel initiatives

19 January, 2021

Dubai explores new markets in Africa

Costa Rica dental tourism revival

19 January, 2021

A strong 2021 for Costa Rica’s dental travel sector?

Abu Dhabi medical travel

14 January, 2021

UAE capital integrates health network for specialist care

Covid-safe certification for medical travel

08 January, 2021

Latest clinics to be GHA certified